Mostrando 2 resultados de: 2
Filtros aplicados
Área temáticas
Enfermedades(1)
Fisiología humana(1)
Medicina forense; incidencia de enfermedades(1)
Problemas sociales y servicios a grupos(1)
Origen
scopus(2)
An analysis of the safety of the single dose, two drug regimens used in programmes to eliminate lymphatic filariasis
ReviewAbstract: This review of the safety of the co-administration regimens to be used in programmes to eliminate lyPalabras claves:Adverse events, albendazole, Brugia malayi, DEC, Diethylcarbamazine, Drug regimens for LF, drug safety, Ivermectin, Lymphatic filariasis, Programme to Eliminate Lymphatic Filariasis (PELF), Tropical disease control, Wuchereria bancroftiAutores:Addiss D.G., Awadzi K., Beach M.J., Belizario V.Y., Dunyo S.K., Gyapong J.O., Horton J., Hossain M., Ismail M.M., Jayakody R.L., Lammie P.J., Lazdins J.K., Makunde W., Mauricio Espinel, Ottesen E.A., Richard-Lenoble D., Selve B., Shenoy R.K., Simonsen P.E., Wamae C.N., Weerasooriya M.V., Witt C.Fuentes:scopusEosinophil sequestration and activation are associated with the onset and severity of systemic adverse reactions following the treatment of onchocerciasis with ivermectin
ArticleAbstract: To investigate the role of eosinophil activation and sequestration in the development and severity oPalabras claves:Autores:Awadzi K., Nutman T.B., Ottesen E.A., Philip John Cooper, Remick D.G.Fuentes:scopus